MoneyWorks4Me

The sales moved up 33.11% to Rs. 4173.40 millions for the September 2026 quarter as compared to Rs. 3135.40 millions during the year-ago period.The Total Profit for the quarter ended September 2026 of Rs. 296.10 millions grew from Rs.-100.80 millionsOperating Profit saw a handsome growth to 771.10 millions from 352.40 millions in the quarter ended September 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 4173.40 3135.40 33.11 7989.40 6326.90 26.28 13689.80 12837.60 6.64
Other Income 2.30 4.90 -53.06 21.50 14.70 46.26 58.90 91.40 -35.56
PBIDT 771.10 352.40 118.81 1410.40 932.50 51.25 1925.70 2129.80 -9.58
Interest 163.60 208.30 -21.46 365.90 447.30 -18.20 942.40 1148.10 -17.92
PBDT 562.50 144.10 290.35 999.50 485.20 106.00 924.40 981.70 -5.84
Depreciation 266.40 244.90 8.78 533.50 480.70 10.98 996.80 992.50 0.43
PBT 296.10 -100.80 -393.75 466.00 4.50 10255.56 -72.40 -10.80 570.37
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 296.10 -100.80 -393.75 466.00 4.50 10255.56 -72.40 -10.80 570.37
Equity 481.60 444.70 8.30 481.60 444.70 8.30 445.10 402.50 10.58
PBIDTM(%) 18.48 11.24 64.39 17.65 14.74 19.78 14.07 16.59 -15.21
Peers
Company Name CMP
Sun Pharma. Inds. 1742.95
Dr. Reddys Labs. 1310.00
Cipla 1348.80
Lupin 1950.00
Zydus Lifesciences 1157.15
View more..